Stoke Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

Stoke Therapeutics, Inc. reported Common Stock Shares Outstanding of 58.92 million shares for the year ending 2025.

  • Stoke Therapeutics, Inc. showed an increase of +9.0% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Stoke Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Stoke Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 8,000.2%.
  • Historical annual values: Fiscal year 2025: 58.92 million shares | Fiscal year 2024: 54.03 million shares | Fiscal year 2023: 45.92 million shares | Fiscal year 2022: 39.44 million shares | Fiscal year 2021: 36.90 million shares | Fiscal year 2020: 36.58 million shares | Fiscal year 2019: 32.86 million shares | Fiscal year 2018: 727,413 shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: